Protective low avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cells
Abstract
Regulatory T cells (Treg) play a major role in the suppression of protective anti-tumour T cell responses. In the CT26 BALB/c murine model of colorectal carcinoma, Tregs differentially suppress responses to two characterised CD8+ T epitopes, AH1 and GSW11, which results in an absence of detectable IFN-{gamma} producing GSW11- specific T cells in the spleen and lymph nodes of tumour challenged mice. Activation of GSW11-specific T cells correlates with protection against tumour growth. Here we show that GSW11-specific T cells are in fact induced in Treg-replete, CT26-bearing mice, where they make up the majority of tumour infiltrating CD8+ lymphocytes, but exhibit a dysfunctional exhausted phenotype. This dysfunctional phenotype is induced early in the anti-tumour response in draining lymph nodes, spleens and tumours and is significantly more pronounced in GSW11-specific T cells compared to other tumour-specific T cell responses. Depletion of Tregs prior to tumour challenge significantly reduces the induction of exhaustion in GSW11-specific T cells and correlates with altered T cell receptor (TcR) usage. Moreover, the avidity of GSW11- specific TcRs that expanded in the absence of Tregs was significantly lower compared to TcRs of cytotoxic T lymphocyte (CTL) populations that were diminished in protective anti-tumour responses. This indicates that Tregs suppress the induction of protective anti-tumour T cell responses and may signify that the induction of low avidity T cells, while being more susceptible to exhaustion are the most efficacious in tumour rejection.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bcl6 Preserves the Suppressive Function of Regulatory T Cells during Tumorigenesis
Y. Li, Z. Wang, … L. Xu·Frontiers in ImmunologyPeer-reviewed·May 12, 2020
- Intra-Tumoral Treg Ablation Unleashes NK Cell-Mediated Control of CD8 T Cell-Resistant Tumors
Chenyu Zhang, Charles Chien, … David H. Raulet·Science ImmunologyPeer-reviewed·Apr 10, 2026
- Expression of Tim-3 drives naive Treg to an effector-like state with enhanced suppressive activity
H. Banerjee, H. Nieves-Rosado, … L. P. Kane·bioRxiv·Jul 31, 2020
- PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression
Qiyuan Yang, Yuqiong Liang, … Ye Zheng·bioRxiv·Dec 16, 2024
- Interaction with tumor cell spheroids induces suppression in primary human cytotoxic T cells
Amal Alsubaiti, Hanin Alamir, … Christoph Wülfing·Immunotherapy AdvancesPeer-reviewed·Dec 30, 2024
- Lack of Bcl6 promotes anti-tumor immunity by activating glycolysis to rescue CD8 T cell function
Fangkun Luan, Yunqiao Li, … David A. Nemazee·bioRxiv·Apr 1, 2025